TACLONEX SUMMARY
TACLONEX ® OINTMENT
(calcipotriene 0.005% and betamethasone dipropionate 0.064%)
Taclonex® Ointment contains calcipotriene hydrate and betamethasone dipropionate. It is intended for topical use.
Calcipotriene hydrate is a synthetic vitamin D3 analogue.
Betamethasone dipropionate is a synthetic corticosteroid.
Each gram of Taclonex® Ointment contains 52.18 mcg of calcipotriene hydrate (equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) in an ointment base of mineral oil, PPG-15 stearyl ether, dl-alpha tocopherol and white petrolatum.
Taclonex® Ointment is indicated for the topical treatment of psoriasis vulgaris in adults 18 years of age and above for up to 4 weeks. The maximum weekly dose should not exceed 100 g. Treatment of more than 30% body surface area is not recommended.
Taclonex® Ointment should not be applied to the face, axillae or groin.
|
